Targeting Toxins toward Tumors
Many cancer diseases, e.g., prostate cancer and lung cancer, develop very slowly. Common chemotherapeutics like vincristine, vinblastine and taxol target cancer cells in their proliferating states. In slowly developing cancer diseases only a minor part of the malignant cells will be in a proliferati...
Main Authors: | Henrik Franzyk, Søren Brøgger Christensen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/5/1292 |
Similar Items
-
Preparation of Enzyme-Activated Thapsigargin Prodrugs by Solid-Phase Synthesis
by: Tomas Zimmermann, et al.
Published: (2018-06-01) -
Progress towards hypoxia-activated SN-38: the potential to target hypoxic tumors
by: Liang, Dinghua
Published: (2016) -
Synthesis and Total 1H- and 13C-NMR Assignment of Cephem Derivatives for Use in ADEPT Approaches
by: Man-Chin Chung, et al.
Published: (2008-04-01) -
Synthese und biologische Evaluation neuartiger Duocarmycin-Analoga für eine selektive Krebstherapie
by: Pestel, Galina Farina
Published: (2013) -
Targeted Prodrug-Based Self-Assembled Nanoparticles for Cancer Therapy
by: Wang W, et al.
Published: (2020-04-01)